Source: Atherosclerosis. Unidade: FM
Subjects: FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, BIOMARCADORES
ABNT
LAURINAVICIUS, A et al. Apolipoprotein A-IV as a marker of subclinical vascular disease among individuals with hyperalphalipoproteinemia. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.718. Acesso em: 15 out. 2024. , 2017APA
Laurinavicius, A., Passarelli, M., Nakandakare, E. R., Hong, V., Bortolotto, L., Conceição, R., & Santos Filho, R. D. dos. (2017). Apolipoprotein A-IV as a marker of subclinical vascular disease among individuals with hyperalphalipoproteinemia. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.718NLM
Laurinavicius A, Passarelli M, Nakandakare ER, Hong V, Bortolotto L, Conceição R, Santos Filho RD dos. Apolipoprotein A-IV as a marker of subclinical vascular disease among individuals with hyperalphalipoproteinemia [Internet]. Atherosclerosis. 2017 ; 263 e220.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.718Vancouver
Laurinavicius A, Passarelli M, Nakandakare ER, Hong V, Bortolotto L, Conceição R, Santos Filho RD dos. Apolipoprotein A-IV as a marker of subclinical vascular disease among individuals with hyperalphalipoproteinemia [Internet]. Atherosclerosis. 2017 ; 263 e220.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.718